![]() |
市場調查報告書
商品編碼
1984894
全球嬰幼兒營養食品市場:按性質、形式、類型、年齡層和分銷管道分類-市場規模、產業動態、機會分析和預測(2026-2035 年)Global Infant Nutrition Market: By Type, Distribution Channel - Market Size, Industry Dynamics, Opportunity Analysis and Forecast for 2026-2035 |
||||||
全球嬰幼兒營養品市場正經歷顯著成長,預計2025年將達到610.3億美元。這一成長趨勢預計將持續強勁,到2035年市場規模預計將迅速擴張至1,620.8億美元。預測期內,該市場複合年成長率將達到10.26%,顯示儘管面臨各種人口結構挑戰,市場需求依然強勁且持續。這一顯著成長不僅反映了人們對嬰幼兒健康和營養意識的提高,也體現了消費者偏好的轉變,他們更加重視產品的品質和專業的配方。
推動市場成長的最顯著趨勢之一是向高利潤產品轉型,這些產品強調臨床功效和有機成分。現今的父母更了解產品,也更具鑑賞力,他們要求嬰兒配方奶粉具有科學依據支持的功效,並且不含任何有害化學物質和合成添加劑。這種對優質化的關注意味著品牌正在大力投資研發,以開發出能夠解決特定健康問題(例如過敏、消化健康和認知發育)的配方奶粉,同時滿足消費者對有機和天然產品日益成長的需求。
嬰兒營養品市場的「四大巨頭」——雀巢、達能、雅培和利潔時——繼續主導著該行業,合計佔超過60%的市場佔有率。這些大型公司越來越注重嬰兒營養的“醫療化”,其戰略核心是強調特定的健康益處,例如過敏管理,以及解決與嬰兒生長相關的問題。
同時,美國的ByHeart、英國的Kendamil和中國的Biostime等新興品牌正以截然不同的方式為產業帶來全新視野。這些顛覆者並非著眼於藥效,而是關注生產過程和原料的透明度。他們透過推廣加工更少、成分潔淨標示的產品,挑戰傳統的生產方式,以滿足日益關注添加劑、人工成分以及嬰幼兒食品整體純度的父母的需求。
這些發展趨勢正在嬰幼兒營養品市場中形成一種有趣的兩極化。一方面,老牌巨頭繼續以科學的醫學聲明和大規模創新為導向;另一方面,小規模、更靈活的品牌則專注於透明度、極簡加工和天然成分,引領行業創新。這種張力正在推動持續創新和多元化發展,最終擴大消費者的選擇範圍,並塑造市場的未來方向。
主要成長促進因素
「植物性2.0革命」正成為嬰幼兒營養市場成長的關鍵驅動力。這項轉變主要受兩大社會和健康趨勢的推動,這兩大趨勢正在重塑消費者的偏好和需求。推動這場革命的主要因素之一是嬰幼兒牛奶蛋白過敏(CMPA)盛行率的上升。 CMPA是一種常見的食物過敏,影響全球越來越多的嬰幼兒。因此,家長和醫療保健專業人員正在尋找不含牛奶蛋白的替代營養來源。 CMPA發病率的上升導致植物來源嬰幼兒配方奶粉市場顯著擴張。這些產品為患有CMPA的嬰幼兒提供了安全有效的選擇,確保他們獲得必需的營養,而無需擔心有害的過敏反應。
新機會的趨勢
基於DNA的個人化營養正成為嬰幼兒營養市場中一個充滿前景且極具創新性的機遇,擁有巨大的成長潛力。這種前沿方法利用基因組學和微生物組學的最新進展,提供高度客製化的營養解決方案,以滿足每個嬰兒的獨特需求。透過分析嬰兒的基因組成和腸道微生物組,製造商可以開發個人化配方奶粉和益生菌補充劑,以解決特定的營養缺乏問題,並支持嬰兒的最佳健康狀態。這種高度客製化的理念標誌著嬰幼兒營養從傳統的、千篇一律的配方奶粉向精準營養的重大轉變,吸引了越來越多希望為孩子提供最佳呵護的父母的關注。
最佳化障礙
更嚴格的監管對嬰兒配方奶粉市場的成長構成重大挑戰。世界衛生組織(世衛組織)和聯合國兒童基金會等國際組織長期以來一直倡導母乳哺育是嬰兒的最佳營養來源,尤其是在出生後的前六個月。他們持續進行宣傳活動,積極鼓勵在這段關鍵時期減少配方奶粉的使用,強調母乳的健康益處以及過早替代的風險。這些努力影響了各國的政策和公眾輿論,創造了一個要求配方奶粉生產商謹慎行事的環境。
The global infant nutrition market is experiencing substantial growth, with its valuation reaching USD 61.03 billion in 2025. This upward trajectory is expected to continue robustly, with projections indicating the market will soar to USD 162.08 billion by 2035. Such growth corresponds to a compound annual growth rate (CAGR) of 10.26% throughout the forecast period, highlighting strong and sustained demand despite various demographic challenges. This impressive expansion reflects not only the increasing awareness of infant health and nutrition but also the evolving preferences of consumers who are prioritizing quality and specialized formulations.
One of the most notable trends driving this market growth is the shift toward high-margin products that emphasize clinical validation and organic ingredients. Parents today are more informed and discerning, seeking infant nutrition options that provide scientifically backed benefits and are free from harmful chemicals or synthetic additives. This focus on premiumization means that brands are investing heavily in research and development to create formulas that address specific health concerns, such as allergies, digestive health, and cognitive development, while also catering to the growing demand for organic and natural products.
The Big Four players in the infant nutrition market-Nestle, Danone, Abbott, and Reckitt-continue to dominate the industry by collectively holding over 60% of the market share. These giants are intensifying their focus on the medicalization of infant nutrition, a strategy that revolves around emphasizing specific health claims such as allergy management and addressing growth-related concerns in infants.
Meanwhile, emerging brands like ByHeart in the United States, Kendamil in the United Kingdom, and Biostime in China are shaking up the sector by taking a very different approach. Rather than focusing primarily on medical claims, these disruptors are honing in on the processing and ingredient transparency angle. They challenge traditional manufacturing methods by promoting less processed, cleaner-label products that appeal to parents who are increasingly concerned about additives, artificial ingredients, and the overall purity of infant nutrition.
This dynamic creates a fascinating duality within the infant nutrition market: on one hand, the established giants continue to push forward with science-based medical claims and large-scale innovation, while on the other hand, smaller, agile brands disrupt the industry by focusing on transparency, minimal processing, and natural ingredients. This tension drives ongoing innovation and diversification, ultimately expanding choices for consumers and shaping the future direction of the market.
Core Growth Drivers
The Plant-Based 2.0 Revolution is becoming a significant force propelling growth within the infant nutrition market. This shift is largely driven by two key societal and health trends that are reshaping consumer preferences and demand. One major factor behind this revolution is the increasing prevalence of Cow's Milk Protein Allergy (CMPA) among infants. CMPA is a common food allergy that affects a growing number of babies worldwide, leading parents and healthcare providers to seek alternative nutrition sources that do not contain cow's milk proteins. This rising incidence has created a substantial market for plant-based infant formulas, which offer safe and effective options for infants with this allergy, ensuring they receive the necessary nutrients without risking adverse allergic reactions.
Emerging Opportunity Trends
DNA-based personalized nutrition is emerging as a promising and innovative opportunity within the infant nutrition market, offering significant potential for growth. This cutting-edge approach leverages advances in genomic and microbiome science to provide highly customized nutritional solutions tailored to the unique needs of each infant. By analyzing a baby's genetic makeup and gut microbiome, manufacturers can develop personalized formulas and probiotic supplements that address specific nutritional deficiencies and support optimal health outcomes. This level of customization represents a significant shift from traditional one-size-fits-all infant formulas toward precision nutrition, which is gaining increasing interest among parents seeking the best possible care for their children.
Barriers to Optimization
Regulatory tightening poses a significant challenge to the growth of the infant milk formula market. International organizations such as the World Health Organization (WHO) and UNICEF have long advocated for breastfeeding as the optimal source of nutrition for infants, especially during the first six months of life. Their ongoing campaigns actively discourage the use of formula feeding during this critical period, emphasizing the health benefits of breast milk and the risks associated with substituting it prematurely. These efforts have influenced national policies and public perception, creating a cautious environment for formula manufacturers.
By Formula Type, the infant milk formula segment firmly established itself as the dominant force within the infant nutrition market. This leadership position is largely the result of substantial investments in research and development by major industry players such as Nestle and Abbott. These companies have focused their efforts on creating formulas that closely replicate the nutritional profile of human breast milk, responding to the demand from parents seeking high-quality alternatives for their infants. The emphasis on scientific innovation has been pivotal in advancing the appeal and effectiveness of infant formulas, making them a trusted choice for many families around the world.
By Distribution Channel, hypermarkets and supermarkets emerged as the leading distribution channels, generating the largest share of revenue in their sector. Their dominant position is largely attributed to the trust they have built with consumers, especially in an environment where concerns about counterfeit products are on the rise. These large, established physical retailers serve as reliable verification hubs where customers feel confident that the products they purchase are genuine and safe. This trust is crucial in maintaining strong sales and customer loyalty, as consumers increasingly seek assurance regarding the authenticity and quality of the items they buy.
Geography Breakdown